Inventor
Anne-Marie Pinel
Inventor
Castres, FR
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07KPeptides10%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture10%
A61QSpecific use of cosmetics or similar toiletry preparations9%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for3%
C08BPolysaccharides3%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
8,097,590'α-MSH-antagonist dipeptide conjugates'20128,017,581'MSH-agonist tripeptide conjugates'20117,785,577'Peptides or peptidic conjugate derivatives of MSH and the use thereof for cosmetically fighting against canities'20107,507,719'Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment'20097,404,948'Peptidic conjugates for alopecia prevention and treatment'20087,268,108'Alpha-melanocyte stimulating hormone derivatives and cosmetic application thereof'20076,211,155'Peptide conjugates derived from thymic hormones, their use as a medicament and compositions containing them'20015,830,994'Peptide derivatives of alpha-MSH and their application'19985,362,474'Method for detecting and locating inflammatory or tumor foci in a patient and diagnostic kit therefor'19944,937,327'Derivative of D.25, process for its preparation, its use as an immunostimulant, and pharmaceutical compositions containing the derivative'19904,933,440'Immunomodulators obtained semisynthetically from a bacterial polysaccharide isolated from a non-encapsulated mutant strain of Klebsiella pneumoniae'19904,734,403'Membrane polysaccharides which are useful as immunostimulants'19884,501,693'Method of preparing immunostimulant proteoglycans which induce production of interferon, proteoglycans obtained and pharmaceutical compositions containing them'19854,460,575'Vaccinal complex containing a specific antigen and vaccine containing it'19844,397,838'Preparations of purified bacterial membranal proteoglycans'19834,389,396'Immunostimulating preparations based on ribosomal RNA\'s and a process for the preparation of the RNA\'s'19834,297,272'Process for the preparation of purified bacterial membranal proteoglycans'1981Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1981–1985Patents assigned to FABRE SA PIERRE (5)· patent assignee history
1981–1994Based in Castres, FR· patent location history
1988–1994Patents assigned to PF MEDICAMENT (4)· patent assignee history
1998–2012Patents assigned to INST EUROPEEN BIOLOG CELLULAIR (6)· patent assignee history
1998–2012Based in Toulouse, FR· patent location history
2001Based in La Grande Motte, FR· patent location history
2010–2012Patents assigned to CENTRE NAT RECH SCIENT (3)· patent assignee history
2010–2012Patents assigned to UNIV MONTPELLIER I (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INST EUROPEEN BIOLOG CELLULAIR | 6 | 1998–2012 |
| FABRE SA PIERRE | 5 | 1981–1985 |
| PF MEDICAMENT | 4 | 1988–1994 |
| CENTRE NAT RECH SCIENT | 3 | 2010–2012 |
| UNIV MONTPELLIER I | 3 | 2010–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Castres, FR | 9 | 1981–1994 |
| Toulouse, FR | 7 | 1998–2012 |
| La Grande Motte, FR | 1 | 2001 |